¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"myasthenia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® myasthenia gravis ÇÑ±Û ÁßÁõ±ÙÀ°¹«·ÂÁõ
¼³¸í   
  È°µ¿½Ã¿¡ ±Ù´ë¾à°ú ÇǷθ¦ È£¼ÒÇÏ´Ù°¡ ¾ÈÁ¤ ÈÄ¿¡´Â È¸º¹µÇ´Â Æ¯Â¡ÀûÀΠÁõ»óÀ» È£¼ÒÇϴ º´À¸·Î, ±ÙÀ°°ú ½Å°æÁ¢ÇպΠ»çÀÌ ¿¬°áºÎºÐ ÀÌ»óÀ¸·Î ¹ß»ýÇÑ´Ù. ÁַΠÀþÀº ¿©¼º¿¡¼­ ºó¹ßÇϰí, ´«ÁÖÀ§ ±ÙÀ°À» Àߠħ¹üÇÑ´Ù. ´ë°³ ¾ÆÄ§À̳ª È޽ĠÈÄ¿¡´Â È£ÀüµÇ¾ú´Ù°¡ ¿îµ¿½Ã ¾ÇÈ­µÇ´Â ÇÇ·ÎÇö»óÀ» º¸ÀδÙ. ¸ÞÄ¿´ÏÁòÀº ¾Æ¸¶ ¸é¿ª°èÀÇ ÀÌ»óÀ¸·Î ÀÎÇØ ¹ß»ýÇϴ °ÍÀ¸·Î º¸À̸ç, Ä¡·á ¶ÇÇÑ ¸é¿ªÀ» ¾ïÁ¦Çϴ ¾àÀ» ´Ù·® Åõ¿©ÇÔÀ¸·Î½á È£ÀüµÇ¾ú´Ù´Â º¸°í°¡ ¸¹´Ù. Ä§¹üºÎÀ§ÀÇ ±ÙÀ°¿¡ µû¶ó ¿©·¯ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç, È£Èí±Ù±îÁö Ä§¹üÇϰԠµÇ¸é, È£Èí±â´É»ó½Ç·Î »ç¸ÁÇÑ´Ù. ½Å°æ-±ÙÀ° Á¢ÇպΠÁß Á¢ÇÕµÚ¸·ÀÇ ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëüÀÇ Àå¾Ö°¡ ¹ß»ýÇϴ ÀÚ°¡¸é¿ªº´ÀÌ´Ù. µû¶ó¼­ ½Å°æ-±ÙÀ° Á¢Çպο¡¼­ ½Å°æÀڱؠÀü´ÞÀÌ Â÷´ÜµÇ¾î ±ÙÀ°¼è¾à°ú Á¶±â ÇǷΰ¡ ¿Â´Ù. È¯ÀÚÀÇ 85~90%¿¡¼­ Ç÷Áß¿¡ ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü¿¡ ´ëÇÑ Ç×ü°¡ ÀÖ´Ù. ÀüÀÚÇö¹Ì°æÀ¸·Î °üÂû½Ã ½Å°æ ±ÙÀ° Á¢ÇպΠÁ¢ÇÕÁÖ¸§ °¨¼Ò ¹× ´Ü¼øÈ­¸¦ º¸ÀδÙ. È¯ÀÚÀÇ 15~50%´Â °¡½¿»ùÁ¾°ú µ¿¹ÝµÇ°í ³ª¸ÓÁö´Â °¡½¿»ù°ú´ÙÇü¼º°ú Àß µ¿¹ÝµÈ´Ù. ±¤ÇÐÇö¹Ì°æ»ó¿¡¼­´Â 2Çü ±ÙÀ°¼¶À¯ÀÇ À§Ãà°ú Å»½Å°æ¿¡ ÀÇÇÑ ÀÛ°í °¢Áø ±ÙÀ°¼¶À¯°¡ ³ªÅ¸³ª´Â °Í À̿ܿ¡´Â Æ¯º°ÇÑ ¼Ò°ßÀ» º¸ÀÌÁö ¾Ê´Â´Ù.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® myasthenia gravis ÇÑ±Û ÁßÁõ±ÙÀ°¹«·ÂÁõ
¼³¸í   
  È°µ¿½Ã¿¡ ±Ù´ë¾à°ú ÇǷθ¦ È£¼ÒÇÏ´Ù°¡ ¾ÈÁ¤ ÈÄ¿¡´Â È¸º¹µÇ´Â Æ¯Â¡ÀûÀΠÁõ»óÀ» È£¼ÒÇϴ º´À¸·Î, ±ÙÀ°°ú ½Å°æÁ¢ÇպΠ»çÀÌ ¿¬°áºÎºÐ ÀÌ»óÀ¸·Î ¹ß»ýÇÑ´Ù. ÁַΠÀþÀº ¿©¼º¿¡¼­ ºó¹ßÇϰí, ´«ÁÖÀ§ ±ÙÀ°À» Àߠħ¹üÇÑ´Ù. ´ë°³ ¾ÆÄ§À̳ª È޽ĠÈÄ¿¡´Â È£ÀüµÇ¾ú´Ù°¡ ¿îµ¿½Ã ¾ÇÈ­µÇ´Â ÇÇ·ÎÇö»óÀ» º¸ÀδÙ. ¸ÞÄ¿´ÏÁòÀº ¾Æ¸¶ ¸é¿ª°èÀÇ ÀÌ»óÀ¸·Î ÀÎÇØ ¹ß»ýÇϴ °ÍÀ¸·Î º¸À̸ç, Ä¡·á ¶ÇÇÑ ¸é¿ªÀ» ¾ïÁ¦Çϴ ¾àÀ» ´Ù·® Åõ¿©ÇÔÀ¸·Î½á È£ÀüµÇ¾ú´Ù´Â º¸°í°¡ ¸¹´Ù. Ä§¹üºÎÀ§ÀÇ ±ÙÀ°¿¡ µû¶ó ¿©·¯ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç, È£Èí±Ù±îÁö Ä§¹üÇϰԠµÇ¸é, È£Èí±â´É»ó½Ç·Î »ç¸ÁÇÑ´Ù. ½Å°æ-±ÙÀ° Á¢ÇպΠÁß Á¢ÇÕµÚ¸·ÀÇ ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëüÀÇ Àå¾Ö°¡ ¹ß»ýÇϴ ÀÚ°¡¸é¿ªº´ÀÌ´Ù. µû¶ó¼­ ½Å°æ-±ÙÀ° Á¢Çպο¡¼­ ½Å°æÀڱؠÀü´ÞÀÌ Â÷´ÜµÇ¾î ±ÙÀ°¼è¾à°ú Á¶±â ÇǷΰ¡ ¿Â´Ù. È¯ÀÚÀÇ 85~90%¿¡¼­ Ç÷Áß¿¡ ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü¿¡ ´ëÇÑ Ç×ü°¡ ÀÖ´Ù. ÀüÀÚÇö¹Ì°æÀ¸·Î °üÂû½Ã ½Å°æ ±ÙÀ° Á¢ÇպΠÁ¢ÇÕÁÖ¸§ °¨¼Ò ¹× ´Ü¼øÈ­¸¦ º¸ÀδÙ. È¯ÀÚÀÇ 15~50%´Â °¡½¿»ùÁ¾°ú µ¿¹ÝµÇ°í ³ª¸ÓÁö´Â °¡½¿»ù°ú´ÙÇü¼º°ú Àß µ¿¹ÝµÈ´Ù. ±¤ÇÐÇö¹Ì°æ»ó¿¡¼­´Â 2Çü ±ÙÀ°¼¶À¯ÀÇ À§Ãà°ú Å»½Å°æ¿¡ ÀÇÇÑ ÀÛ°í °¢Áø ±ÙÀ°¼¶À¯°¡ ³ªÅ¸³ª´Â °Í À̿ܿ¡´Â Æ¯º°ÇÑ ¼Ò°ßÀ» º¸ÀÌÁö ¾Ê´Â´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia
    ±Ù(À°)¹«·ÂÁõ
  • myasthenia gravis
    ÁßÁõ±Ù(À°)¹«·ÂÁõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia
    ±ÙÀ°¹«·ÂÁõ
  • myasthenia gravis
    ÁßÁõ±ÙÀ°¹«·ÂÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia
    ±ÙÀ°¹«·ÂÁõ
  • myasthenia gravis
    (¢¡gravis) ÁßÁõ±ÙÀ°¹«·ÂÁõ
  • myasthenia ocularis
    ´«±ÙÀ°¹«·ÂÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MG=£¾myasthenia gravis
    ÁßÁõ±Ù¹«·ÂÁõ.
  • MG=£¾myasthenia gravis
    ÁßÁõ ±Ù¹«·ÂÁõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia
    ±Ù¹«·ÂÁõ
  • myasthenia
    ±Ù¹«·ÂÁõ(¡­ÙíÕôñø)
  • myasthenia cardiovascularis ³ª
    Ç÷°ü±Ù¹«·ÂÁõ(úìηÐÉÙíæ³ñø).
  • myasthenia cardiovascularis ³ª
    ½ÉÇ÷°ü±Ù¹«·ÂÁõ(úìηÐÉÙíæ³ñø).
  • myasthenia gastrica ³ª
    À§±Ù¹«·ÂÁõ(êÖÐÉÙíæ³ñø).
  • myasthenia gravis
    ÁßÁõ(ñìñø) ±Ù¹«·ÂÁõ
  • myasthenia gravis juvenilis ³ª
    ¿¬¼Ò¼º ÁßÁõ ±Ù¹«·ÂÁõ.
  • myasthenia gravis pseudoparalytica ³ª
    °¡¼º¸¶ºñ¼º ÁßÁõ±Ù¹«·ÂÁõ.
  • myasthenia gravis syndrome ³ª
    ÁßÁõ±Ù¹«·ÂÁõÈıº(ýªÔéÐÉÙëæ³ñø).
  • myasthenia laryngis <³ª>
    Èĵαٹ«·ÂÁõ
  • myasthenia laryngis ³ª
    Èĵαٹ«·ÂÁõ.
  • myasthenia ocularis ³ª
    ¾È±Ù¹«·ÂÁõ.
  • myasthenia pseudoparalytica ³ª
    °¡¼º¸¶ºñ¼º ±Ù¹«·ÂÁõ.
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • myasthenia gravis
    ÁßÁõ±Ù¹«·ÂÁõ
    ñìñøÐÉÙíÕôñø
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myasthenia gravis
    ÁßÁõ±Ù¹«·ÂÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MG   1) Myasthenia Gravis
  2) MonoGlyceride
  3) Monoclonal Gammop...
CMG canine or congenital myasthenia gravis; chopped meat glucose [medium]; cystometrography, cystometrog...
EAMG experimental autoimmune myasthenia gravis
FIMG familial infantile myasthenia gravis
JAMG juvenile autoimmune myasthenia gravis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
EAMG Experimental Autoimmune Myasthenia Gravis
MG MYASTHENIA GRAVIS
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • G70.0
    Myasthenia gravis
    ÁßÁõ ±ÙÀ°¹«·ÂÁõ
  • G70
    Myasthenia gravis and other myoneural disorders
    ÁßÁõ ±ÙÀ°¹«·ÂÁõ ¹× ±âŸ ±Ù½Å°æ¼º Àå¾Ö
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myasthenia gastrics
    À§ ±Ù ¹«·ÂÁõ
  • myasthenia gravis syndrome
    ÁßÁõ ±Ù¹«·Â ÁõÈıº
  • myasthenia ocularis
    ¾È±Ù ¹«·ÂÁõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myasthenia gastrics
    À§ ±Ù ¹«·ÂÁõ
  • myasthenia gravis syndrome
    ÁßÁõ ±Ù¹«·Â ÁõÈıº
  • myasthenia ocularis
    ¾È±Ù ¹«·ÂÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
myasthenia <anatomy, neurology> Muscular debility, any constitutional anomaly of muscle.
Origin: Gr. Astheneia = weakness
(18 Nov 1997)
myasthenia angiosclerotica <symptom> A symptom complex characterised by leg pain and weakness brought on by walking, with the disappearance of the symptoms following a brief rest.
(12 Dec 1998)
myasthenia gravis <disease, neurology> The characteristic feature of the disease is easy fatigue of certain voluntary muscle groups on repeated use. Muscles of the face or upper trunk are especially likely to be affected. In most and perhaps all cases due to the development of autoantibodies against the acetylcholine receptor in neuromuscular junctions. Immunisation of mice or rats with this receptor protein leads to a disease with the features of myasthenia.
(18 Nov 1997)
myasthenia gravis and thymoma <radiology> Of patients with MG 15% have thymoma, of patients with thymoma 50% have MG
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 3 ÆäÀÌÁö: 1
  • Myasthenia Gravis - »õâ A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the NEUROMUSCULAR JUNCTION, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. THYMOMA is commonly associated with this condition. (Adams et al., Principles of Neurology, 6th ed, p1459)
    Synonyms : Myasthenia Gravis, Generalized, Myasthenia Gravis, Ocular, Generalized Myasthenia Gravis, Ocular Myasthenia Gravis
  • Myasthenia Gravis, Autoimmune, Experimental - »õâ Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor (AChR) (see RECEPTORS, CHOLINERGIC) components results in a myasthenic syndrome that has acute and chronic phases. The motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-AChR antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. Passive transfer of AChR antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. (From Joynt, Clinical Neurology, 1997, Ch 54, p3)
    Synonyms : Autoimmune Experimental Myasthenia Gravis, Experimental Autoimmune Myasthenia Gravis, Passive Transfer, Experimental Myasthenia, Experimental Myasthenia Gravis, Myasthenia Gravis, Autoimmune Experimental, Experimental Myasthenias, Myasthenia, Experimental
  • Myasthenia Gravis, Neonatal - »õâ A disorder of neuromuscular transmission that occurs in a minority of newborns born to women with myasthenia gravis. Clinical features are usually present at birth or develop in the first 3 days of life and consist of hypotonia and impaired respiratory, suck, and swallowing abilities. This condition is associated with the passive transfer of acetylcholine receptor antibodies through the placenta. In the majority of infants the myasthenic weakness resolves (i.e., transient neonatal myasthenia gravis) although this disorder may rarely continue beyond the neonatal period (i.e., persistent neonatal myasthenia gravis). (From Menkes, Textbook of Child Neurology, 5th ed, p823; Neurology 1997 Jan;48(1):50-4)
    Synonyms : Myasthenia Gravis, Neonatal, Persistent, Myasthenia Gravis, Neonatal, Transient, Myasthenia Gravis, Persistent, Neonatal, Myasthenia Gravis, Transient, Neonatal, Neonatal Myasthenia Gravis, Persistent, Neonatal Myasthenia Gravis, Transient
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 3 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 2 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 1 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
myasthenia myasthenia gravis: a chronic progressive disease characterized by chronic fatigue and muscular weakness (especially in the face and neck); caused by a deficiency of acetylcholine at the neuromuscular junctions any muscular weakness
Ãâó: wordnet.princeton.edu/perl/webwn
myasthenia gravis a chronic progressive disease characterized by chronic fatigue and muscular weakness (especially in the face and neck); caused by a deficiency of acetylcholine at the neuromuscular junctions
Ãâó: wordnet.princeton.edu/perl/webwn
myasthenia gravis Myasthenia gravis (MG, Latin: "grave muscle weakness") is a neuromuscular disease leading to fluctuating weakness and fatiguability. It is one of the best known autoimmune disorders and the antigens and disease mechanisms have well been identified. Weakness is caused by circulating antibodies that block acetylcholine receptors at the post-synaptic neuromuscular junction, inhibiting the stimulative effect of the neurotransmitter acetylcholine. ...
Ãâó: en.wikipedia.org/wiki/Myasthenia_gravis
myasthenia gravis a disease in which the muscles, mainly those in the face, eyes, throat, and limbs, become weak and tire quickly; caused by the body's immune system attacking the receptors in the muscles that pick up nerve impulses
Ãâó: www.american-depot.com/services/resources_gl_m.asp
myasthenia gravis Myasthenia gravis is a neuromuscular disease in which there is a failure of the nerves' ability to stimulate and control the actions of certain muscles. See article: Myasthenia gravis in Puppies.
Ãâó: www.peteducation.com/dict_alpha_listing.cfm
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
myasthenia any muscular weakness
myasthenia a chronic progressive disease characterized by chronic fatigue and muscular weakness (especially in the face and neck)
myasthenia a chronic progressive disease characterized by chronic fatigue and muscular weakness (especially in the face and neck)
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 3 ÆäÀÌÁö: 1
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á